Vaccitech (VACC)
NASDAQ: VACC
· Real-Time Price · USD
5.00
0.51 (11.36%)
At close: Nov 06, 2023, 10:00 PM
Vaccitech Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 29.14M | 29.14M | 15.3M | 802K | 7.26M | 13.42M | 30.15M | 44.7M | 38.24M | 32.1M | 15.07M | 268K | 622.26K | 3.85M | 4.33M |
Cost of Revenue | -8.39M | -8.39M | 13.54M | 23.36M | 35.54M | 45.29M | 31.74M | 21.93M | 9.74M | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 22.55M | 22.55M | -13.21M | -22.55M | -28.28M | -31.86M | -1.59M | 22.77M | 28.5M | 32.1M | 15.07M | 268K | 622.26K | 3.85M | 4.33M |
Operating Income | 66.22M | 49.78M | -41.66M | -63.35M | -89.96M | -66.3M | -26.18M | -4.04M | 5.33M | -7.76M | -38.4M | -45.22M | -38.19M | -34.08M | -21.57M |
Interest Income | 2.19M | 1.83M | 1.98M | 2.94M | 3.63M | 4.47M | 4.68M | 3.18M | 1.85M | 818K | 83K | 2K | 2.27K | 2.27K | 2.27K |
Pretax Income | -47.58M | -42.61M | -64.75M | -75.36M | -81.59M | -59.33M | -19.6M | 850K | 8.89M | -3.23M | -33.98M | -51.14M | -46.43M | -41.65M | -29.34M |
Net Income | -49.67M | -44.09M | -62.92M | -73.03M | -77.26M | -54.95M | -15.45M | 5.37M | 11.42M | -1.38M | -33M | -50.87M | -46.21M | -41.49M | -29.15M |
Selling & General & Admin | 36.7M | 25.02M | 34.71M | 33.43M | 46.53M | 34.44M | 14.87M | 6.39M | -4.13M | 8.19M | 27M | 25.12M | 22.75M | 22.55M | 11.15M |
Research & Development | 37.75M | 43.4M | 49.72M | 47.24M | 47.67M | 44.2M | 40.11M | 41.11M | 34.68M | 27.63M | 22.37M | 16.37M | 12.98M | 11.65M | 11.22M |
Other Expenses | n/a | -2K | 308K | 308K | 824K | 826K | 516K | 516K | n/a | n/a | -3K | -3K | -3K | -3K | n/a |
Operating Expenses | 74.45M | 68.42M | 84.43M | 80.67M | 94.21M | 78.65M | 54.98M | 47.5M | 30.56M | 35.82M | 49.37M | 41.49M | 35.73M | 34.2M | 22.36M |
Interest Expense | -116K | -96K | -8K | 9K | 21K | 1.05M | 1.03M | 1.11M | 1.13M | 92K | 92K | 2.67M | 5.28M | 6.25M | 6.25M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1.71M | 16.61M | 41.01M | 61.81M | 94.21M | 78.65M | 54.98M | 47.5M | 30.56M | 35.82M | 49.37M | 41.49M | 35.73M | 34.2M | 22.36M |
Income Tax Expense | 2.03M | 1.46M | -1.78M | -2.27M | -4.27M | -4.34M | -4.12M | -4.47M | -2.42M | -1.75M | -826K | -28K | 35.01K | 1.05M | 1.65M |
Shares Outstanding (Basic) | 40.27M | 39.35M | 39.42M | 39.04M | 38.53M | 38.39M | 37.88M | 37.35M | 37.25M | 37.2M | 37.19M | 35.49M | 34.84M | 24.89M | 34.06M |
Shares Outstanding (Diluted) | 40.27M | 39.35M | 39.42M | 39.04M | 38.53M | 38.41M | 38.01M | 37.35M | 38.16M | 38.17M | 38.35M | 35.49M | 34.84M | 24.9M | 34.06M |
EPS (Basic) | -1.21 | -1.09 | -1.63 | -1.9 | -2.04 | -1.45 | -0.42 | 0.13 | 0.27 | -0.08 | -1.13 | -1.65 | -220.65 | -217.2 | -291.87 |
EPS (Diluted) | -1.21 | -1.09 | -1.63 | -1.9 | -2.04 | -1.45 | -0.42 | 0.13 | 0.27 | -0.08 | -1.13 | -1.65 | -220.65 | -217.2 | -291.87 |
EBITDA | -7.35M | -20.91M | -37.72M | -56.67M | -79.29M | -57.73M | -18.66M | 2.83M | 9.54M | -3.29M | -32.95M | -40.82M | -34.73M | -30M | -17.74M |
EBIT | 39.65M | 24.95M | -39.65M | -61.14M | -84.24M | -60.95M | -36.01M | -12.74M | -4.73M | -13.31M | -13.31M | -27.71M | -20.71M | -21.15M | -21.15M |
Depreciation & Amortization | -5.52M | -4.04M | 2.77M | 5.52M | 9.51M | 8.82M | 9.96M | 8.19M | 4.51M | 3.82M | 1.48M | 602K | 337.4K | 307.4K | 251.4K |